MENU
NCNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NuCana (NCNA) Earnings Date & Reports
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
NCNA is expected to report earnings to fall ∞% to -200 cents per share on November 12
Q3'26
Est.
$-2.00
Q2'26
Beat
by $2.00
Q4'25
Beat
by $12.41
Q3'25
Beat
by $12.92
Q2'25
Missed
by $10.31
The last earnings report on August 13 showed earnings per share of 0 cents, beating the estimate of -200 cents. With 10.45K shares outstanding, the current market capitalization sits at 6.33M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of novel anti-cancer medicines
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
3 Lochside Way
Phone
+44 1313571111
Employees
12
Web
https://www.nucana.com